Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06316804 · ClinicalTrials.gov registry record · NA
Mobile Mental Health Stigma Reduction Intervention Among Black Adults
A NA study of Depression and Anxiety, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT06316804: Recruiting NA study of Depression and Anxiety, sponsored by Massachusetts General Hospital.
NCT06316804 is a NA study of Depression and Anxiety that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 90 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06316804, a NA study of Depression and Anxiety, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
Major depressive and anxiety disorders are highly prevalent in the general population and are a leading cause of disability. Black adults have a high burden of depression and anxiety. This study aims to assess a self- administered video-based intervention to reduce mental illness stigma and medical mistrust among Black adults with moderate to severe depression or anxiety.
Primary Outcome
An adapted version to evaluate the utilization of mental health care services. The self-report questionnaire includes single item questions that will be used such as, "How many appointments have you attended at a Mental Health Care Institution in the past 3 months? Or at another mental health treatment facility?" and "In the past 3 months, how many appointments have you had with a psychologist, psychotherapist, or psychiatrist at a hospital?". Response options are qualitative: "no appointments"
Conditions Studied
Interventions
- BEHAVIORAL Video Intervention 1
- BEHAVIORAL Video Intervention 2
- BEHAVIORAL Video Intervention 3
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2024-03-15 |
| Est. Completion | 2027-07-31 |
| Phase | NA |
What NCT06316804 shows while recruiting
NCT06316804 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (89% lower).
The record links to 5 conditions, with Depression appearing as the primary indexed condition, and to 3 interventions - of which Video Intervention 1 is the first listed.
NCT06316804 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06316804 about?
NCT06316804 is a clinical study titled "Mobile Mental Health Stigma Reduction Intervention Among Black Adults". Major depressive and anxiety disorders are highly prevalent in the general population and are a leading cause of disability. Black adults have a high burden of depression and anxiety. This study aims to assess a self- administered video-based intervention to reduce mental illness stigma and medical ...
What is the current status of trial NCT06316804?
This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2024-03-15. Estimated completion is 2027-07-31.
What conditions does trial NCT06316804 study?
This clinical trial studies the following conditions: Depression, Anxiety, Health Knowledge, Attitudes, Practice, Mobile Phone Use, Stigmatization.
What interventions are being tested in trial NCT06316804?
The interventions under investigation include: Video Intervention 1 (BEHAVIORAL), Video Intervention 2 (BEHAVIORAL), Video Intervention 3 (BEHAVIORAL).
Who is sponsoring clinical trial NCT06316804?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06316804 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06316804's enrollment target sits among peer trials
90 357th of 679 higher than 320 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy